Serious pneumococcal infections are a major global health problem and are vaccine-preventable
Serious pneumococcal diseases caused by Streptococcus pneumoniae – primarily pneumonia and meningitis – are the #1 vaccine-preventable cause of death in children under 5. WHO estimates that up to 1 million children under 5 die each year due to pneumococcal diseases and over 90% of these deaths occurs in developing countries.
In 2000, a new vaccine became available – a 7-valent pneumococcal conjugate vaccine – that is safe and effective in children under 2 years old. 10- and 13-valent formulations are in advanced stages of development. These vaccines are expected to prevent 60-80% of all serious pneumococcal infections in children worldwide. Routine pneumococcal immunization programs in North America and pneumococcal conjugate vaccine efficacy studies in Africa demonstrate that these vaccines have the potential to save millions of children.
Serious pneumococcal infections are a major global health problem and are vaccine-preventable. The World Health Organization estimates that more than 1.6 million people die every year from pneumococcal infections – primarily pneumonia and meningitis – including 800,000 to 1,000,000 children under five years old. 23-valent pneumococcal polysaccharide vaccines are safe and effective for adults and children over 2 years old and multi-valent pneumococcal conjugate vaccines are safe and effective for children under 2 years old.